S A Prigent

1.7k citations

10 papers · 1.5k indexed · h-index 10

Impact in

Oncology top 2%
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions
Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research

Papers in ⓘ

Biotechnology 2
Radiology, Nuclear Medicine and Imaging 4
- Monoclonal and Polyclonal Antibodies Research 4

Co-authors: William J. Gullick (1 shared paper)Kermit L. Carraway (2 shared papers)Lewis C. Cantley (2 shared papers)Stephen P. Soltoff (1 shared paper)WJ Gullick (1 shared paper)N R Lemoine (1 shared paper)Clare Selden (1 shared paper)Gregory D. Plowman (1 shared paper)
Journals: Molecular and Cellular Biology (2 papers)Journal of Biological Chemistry (2 papers)Biochemical Society Transactions (1 paper)British Journal of Cancer (1 paper)The EMBO Journal (1 paper)
Partner nations: United Kingdom United States France

In The Last Decade

S A Prigent

10 papers receiving 1.5k citations

Peers

Countries citing papers authored by S A Prigent

Since Specialization

Citations

This map shows the geographic impact of S A Prigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Prigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Prigent more than expected).

Fields of papers citing papers by S A Prigent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Prigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Prigent. The network helps show where S A Prigent may publish in the future.

Co-authors

The 25 scholars most cited alongside S A Prigent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S A Prigent Line = papers co-authored together S A Prigent links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work
1	ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Molecular and Cellular Biology ·Stephen P. Soltoff, Kermit L. Carraway, S A Prigent, W. G. Gullick, Lewis C. Cantley	1994	446
2	Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. The EMBO Journal ·S A Prigent, William J. Gullick	1994	316
3	Expression of the ERBB3 gene product in breast cancer British Journal of Cancer ·NR Lemoine, DM Barnes, DP Hollywood, CM Hughes, Paul Smith, E Dublin, S A Prigent, WJ Gullick, HC Hurst	1992	203
4	ErbB3 Is Involved in Activation of Phosphatidylinositol 3-Kinase by Epidermal Growth Factor Molecular and Cellular Biology ·Tephen P. Soltoff, Kermit L. Carraway, S A Prigent, W. G. Gullick, Lewis C. Cantley	1994	197
5	Expression of the c-erbB-3 protein in normal human adult and fetal tissues. PubMed ·S A Prigent, N R Lemoine, C M Hughes, Gregory D. Plowman, Clare Selden, WJ Gullick	1992	149
6	Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. Journal of Biological Chemistry ·S A Prigent, Keith K. Stanley, Kenneth Siddle	1990	73
7	Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity. Journal of Biological Chemistry ·G R Johnson, S A Prigent, W.J. Gullick, Kurt Stromberg	1993	29
8	Modulation of signal-transduction pathways by chemopreventive agents Biochemical Society Transactions ·Margaret M. Manson, Karen Holloway, Lynne Howells, E A Hudson, Simon Plummer, Matthew Squires, S A Prigent	2000	26
9	Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide. PubMed ·Yunfang Ma, S A Prigent, T L Born, Craig Monell, James R. Feramisco, Bonnie L. Bertolaet	1999	19
10	Cutaneous events during treatment of chronic inflammatory joint disorders with anti‐tumour necrosis factor alpha: a cross‐sectional study Journal of the European Academy of Dermatology and Venereology ·AC Davaine, Alain Saraux, S A Prigent, I. Kupfer‐Bessaguet, D Roswag, P. Plantin, P. Schoenlaub, F Talarmin, A. Zagnoli, L. Misery	2008	15

About S A Prigent

S A Prigent is a scholar working on Biotechnology, Radiology, Nuclear Medicine and Imaging, Oncology, Pharmacology and Dermatology, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (2 papers), Glycosylation and Glycoproteins Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Telomeres, Telomerase, and Senescence (1 paper), Neuroblastoma Research and Treatments (1 paper) and Dermatology and Skin Diseases (1 paper). The work is most often cited by research in Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (644 citations), Immunology and Allergy (146 citations), Molecular Biology (864 citations) and Genetics (62 citations). S A Prigent has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include William J. Gullick, Kermit L. Carraway, Lewis C. Cantley, Stephen P. Soltoff, WJ Gullick, N R Lemoine, Clare Selden, Gregory D. Plowman, Kenneth Siddle and Keith K. Stanley. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, Biochemical Society Transactions, British Journal of Cancer and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact